+180.9%
GSK vs RSG
+2,274.1%
-2,093.2%
-51.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | RSG | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.3% | -1.5% | +0.2% | -1.0% |
| 7D | -3.1% | -0.1% | -3.1% | -3.1% |
| 30D | -0.9% | +8.8% | -9.7% | -2.6% |
| 3M | -4.2% | +15.2% | -19.4% | -6.8% |
| 6M | -1.6% | +16.9% | -18.5% | -4.7% |
| YTD | +2.6% | +19.0% | -16.4% | -1.1% |
| 1Y | +6.2% | +17.9% | -11.6% | +2.6% |
| 3Y | +55.0% | +62.4% | -7.5% | +40.1% |
| 5Y | +42.8% | +93.0% | -50.1% | +24.2% |
| 10Y | +102.1% | +434.6% | -332.5% | +45.9% |
| All | +180.9% | +2,274.1% | -2,093.2% | +82.4% |
Cumulative growth
Daily Returns
Daily percentage return beside RSG.
Daily Out/Under-Performance
Portfolio return minus RSG return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RSG return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded RSG wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling